CENTER UPDATE | Late Winter 2020

This update features policy developments, media reports, and new resources
supporting continued momentum for multiple V-BID Center initiatives.

Click here to view recent policy developments.

Click here to view our new resources.

Click here to view recent news stories relevant to V-BID.

Click here to view recent literature relevant to V-BID.

HHS Proposed Rule Offers Support for V-BID X Health Plans

In the proposed 2021 Notice of Benefit and Payment Parameters rule, the Department of Health and Human Services declared broad support for the inclusion of V-BID principles in marketplace health plans.

Trump Administration Wants to Lower Seniors' Insulin Costs

The Trump Administration, in collaboration with the Department of Health and Human Services and the Centers for Medicare and Medicaid Services, is working on a policy to lower seniors’ out-of-pocket costs for insulin. To learn more about V-BID and drug costs, visit our website.

New V-BID Policy Infographic

Our new infographic outlines the principles of value-based insurance design and illustrates how V-BID X can serve as a template for expanding pre-deductible coverage/lowering consumer cost-sharing on high value services through identifying, measuring, and reducing low-value care.

V-BID X for Employers: A Framework Designed to Promote Employee Access to High-Value Drugs, Services

In a recent webinar on V-BID X, Mark Fendrick, MD, V-BID Center director, and Suzanne F. Delbanco, PhD, executive director of Catalyst for Payment Reform, discussed the untapped potential of V-BID in health policy.

As Out-Of-Pocket Health Costs Rise, Insured Adults Are Seeking Less Primary Care

Patient cost-sharing for primary care visits has increased, and in turn Americans are receiving less care, especially those with low incomes. At the same time, visits for preventive care increased, likely spurred by the passage of the Affordable Care Act.

One In Four Cancer Survivors Can’t Afford Their Medical Care–And We’re Blaming The Wrong People

High out-of-pocket costs for high-value care are a burden on patients undergoing treatment for cancer, and this article supports the idea that high-value care shouldn’t come at significant out-of-pocket cost to the patient.

Spending on Low-Value Services Slowed From 2014 to 2016

Despite ample research dedicated to identifying low-value care, reducing utilization has been a slow-moving process. Visit our initiative page for resources on how to identify, measure, report, and reduce low-value care.

Thinking Beyond The Rebate Debate: Strategies To Bring Value To Healthcare

Despite the long-standing debate over drug costs, Americans are still struggling to afford their prescriptions. This article recommends value-based benefit design as a way to tackle the root of the issue, and to decrease costs for consumers.

Expand Pre-deductible Coverage Without Increasing Premiums or Deductibles

In this editorial, Mark Fendrick, MD, outlines how a new IRS rule allows for high-deductible health plans to better serve their beneficiaries with chronic conditions, and even suggests a plan for how to pay for it.

A Successful but Underused Strategy for Reducing Low-Value Care: Stop Paying for It

Low-Value Care costs consumers millions of dollars annually, and is often harmful to its recipients. Rather than just educating providers and consumers about the risks of unnecessary care, non-coverage has the ability to drastically reduce utilization.

Association of Medication Adherence and Clinical Outcomes in Sarcoidosis

Sarcoidosis, a common lung disease, disproportionately affects African Americans, both in terms of incidence and outcomes. The results of this study demonstrate that medication adherence is associated with better quality of life, making it a key target for improving outcomes and eliminating health disparities.

Please Help Support the V-BID Center

As a non-profit entity, the V-BID Center relies on fundraising to support our research, education, and policy efforts. Please help us continue our work by donating here. We truly appreciate your consideration.